From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study
KDSS(n=13) | KD(n=91) | P value | |
---|---|---|---|
Diagnosis | |||
Initial diagnosis of KD | 23.1% (3/13) | 80.2% (73/91) | 0.000 |
Complete KD | 46.2% (6/13) | 67.0% (61/91) | 0.214 |
Incomplete KD | 38.5% (5/13) | 29.7% (27/91) | 0.532 |
Treatment | |||
1st IVIG | 84.6% (11/13) | 98.9% (90/91) | 0.041 |
2nd IVIG | 76.9% (10/13) | 19.8% (18/91) | 0.000 |
Oral prednisolone | 7.7% (1/13) | 11.0% (10/91) | 1.000 |
Methylprednisolone pulse therapy | 38.5% (5/13) | 11.0% (10/91) | 0.020 |
Infliximab | 15.4% (2/13) | 0.0% (0/91) | 0.015 |
Antibiotics | 92.3% (12/13) | 15.4% (14/91) | 0.000 |